Skip Navigation

Strengthening the evidence for maternal and child health programs

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.


Displaying records 1 through 20 (104 total).

American Council for Drug Education. n.d.. Drugs may harm your unborn baby: Only take drugs your doctor prescribes. Washington, DC: American Council for Drug Education, 1 poster (17 x 22 inches).

Barzel R, Holt K. 2019. Opioids and children and adolescents: Information for oral health professionals. Washington, DC: National Maternal and Child Oral Health Resource Center, 6 pp.

Annotation: This document provides guidance on opioids for oral health professionals. It includes information about assessing children and adolescents, drugs to recommend before prescribing opioids, prescribing opioids with caution and being aware of the potential for misuse or abuse, and understanding laws, policies, and recommendations. The document also discusses providing post-operative instructions and creating a safe, friendly environment. Information about prescription-drug-monitoring programs and managing acute oral pain are included, along with tips for dentists to share with parents and an overview of research. [Funded by the Maternal and Child Health Bureau]

Contact: National Maternal and Child Oral Health Resource Center, Telephone: (202) 784-9771 E-mail: OHRCinfo@georgetown.edu Web Site: https://www.mchoralhealth.org Available from the website.

Keywords: Adolescent health, Child health, Drug abuse, Narcotics, Oral health, Pain, Prescription drugs, Prevention

American Dental Association Health Policy Institute. 2018. Opioid prescribing by dentists. American Dental Association Health Policy Institute, 1 p.

Annotation: This infographic provides information about trends in the percentages of opioids prescribed by dentists to individuals with private dental insurance between 2010 and 2015. Total percentages are provided, as well as percentages by age group. Information about days’ supply and quantities of pills prescribed by dentists to individuals with private insurance for 2010–2015 is also presented.

Contact: American Dental Association, Health Policy Institute, 211 East Chicago Avenue, Chicago, IL 60611-2678, Telephone: (312) 440-2500 Web Site: http://www.ada.org/en/science-research/health-policy-institute

Keywords: , Narcotics, Oral health, Oral health care, Prescription Drugs, Statistical data, Trends

Oregon Pregnancy and Opioids Workgroup. 2018. Oregon Pregnancy and Opioids Workgroup recommendations. Salem, OR: Oregon Health Authority, Public Health Division, 27 pp.

Annotation: This document provides recommendations for the management of opioid use for pregnant women, including pregnant women with opioid-use disorder, and for care of the opioid-exposed newborn. Topics include clinical recommendations, health-systems and policy recommendations, definitions, and resources and collaborative approaches.

Contact: Oregon Health Authority, 500 Summer Street, N.E., E-20, Salem, OR 97301-1097, Telephone: (503) 947-2340 Secondary Telephone: (877) 398-9238 Fax: (503) 947-2341 E-mail: OHPBinfo@state.or.us Web Site: http://www.oregon.gov/oha Available from the website.

Keywords: Narcotics, Oral health, Oregon, Pregnant women, Prescription drugs, State programs, Substance abuse, Substance dependence

Barzel R, Holt K, Kolo S. 2018. Prescribing opioids for women of reproductive age: Information for dentists. Washington, DC: National Maternal and Child Oral Health Resource Center, 4 pp.

Annotation: This document provides an overview of pain management for dental procedures for women of reproductive age and discusses pharmacological considerations for pregnant women (pharmaceutical agents and indications, contraindications, and special considerations), neonatal opioid withdrawal syndrome, guidelines for providing opioids, managing acute dental pain, and guidelines for discharging women with opioid prescriptions. Information about prescription drug monitoring programs is included. [Funded by the Maternal and Child Health Bureau]

Contact: National Maternal and Child Oral Health Resource Center, Telephone: (202) 784-9771 E-mail: OHRCinfo@georgetown.edu Web Site: https://www.mchoralhealth.org Available from the website.

Keywords: , Drug addiction, Guidelines, Narcotics, Neonatal abstinence syndrome, Oral health, Pain relieving drugs, Pregnant women, Prescription drugs

U.S. Substance Abuse and Mental Health Services Administration. 2018. Medicaid coverage of medication-assisted treatment for alcohol and opioid use disorders and of medication for the reversal of opioid overdose. Rockville, MD: U.S. Substance Abuse and Mental Health Services Administration, 113 pp.

Annotation: This report presents summary information on Medicaid coverage and financing of medications to treat alcohol and opioid use disorders (MAT). It discusses issues including prior authorization, innovative approaches to financing and delivering MAT, state considerations for covering MAT (including efficacy, costs, regulations, and policies), and innovative models and best practices.

Contact: U.S. Substance Abuse and Mental Health Services Administration, One Choke Cherry Road, Rockville, MD 20857, Telephone: (877) SAMHSA-7 Secondary Telephone: (877) 726-4727 E-mail: Web Site: http://www.samhsa.gov Available from the website. Document Number: HHS SMA-18-5093 .

Keywords: Alcohol dependence, Drugs, Health care financing, Medicaid, Opiates, Substance abuse treatment

Before the First Tooth. [2017]. Rx: Bring this with you to your next appointment [Prescription referral form]. Portland, ME: Before the First Tooth, 1 p.

Annotation: This referral form for health professionals to fill out provides information that pregnant women can bring to their next dental appointment. The form includes blanks to fill in the woman’s name, date of birth, estimated delivery date, and known allergies and boxes to check indicating what types of oral health care are acceptable for the woman to receive and whether there are any precautions to note. Also included are boxes to check indicating pain medications and antibiotics that are safe for the woman. [Funded by the Maternal and Child Health Bureau]

Contact: From the First Tooth / Before the First Tooth, c/o MaineHealth, 110 Free Street, Portland, ME 04101, Telephone: (207) 662-6296 E-mail: info@fromthefirsttooth.org Web Site: http://www.fromthefirsttooth.org Available from the website.

Keywords: Antibiotics, Drugs, Oral health Dental care, Pregnant women

Clevenger AA. 2017. Overdose poisoning deaths to children in Virginia, 2009-2013. Richmond, VA: Virginia Department of Health, Office of the Chief Medical Examiner, 57 pp.

Annotation: This report presents findings, conclusions, and recommendations from case reviews of overdose poison deaths among infants, children, and adolescents up to age 17 in Virginia for the five year period between 2009 and 2013. Topics include how overdose is impacting infants and children and their families in Virginia, which children are at risk, where are they at risk, how are they at risk, and what can be done to further promote health and safety in their lives. [Funded in part by the Maternal and Child Health Bureau]

Contact: Virginia Department of Health, Office of the Chief Medical Examiner, 400 East Jackson Street, Richmond, VA 23219, Telephone: (804) 786-3174 Fax: (804) 371-8595 E-mail: OCME_CENT@vdh.virginia.gov Web Site: http://www.vdh.virginia.gov/medical-examiner Available from the website.

Keywords: Adolescents, Case studies, Child death review, Child safety, Children, Health promotion, High risk groups, Household safety, Infants, Injury prevention, Opiates, Poisoning, Prescription drugs, Virginia

Illinois Department of Public Health. 2017. Antiobiotic stewardship toolkit for dental providers. Sringfield, IL: Illinois Department of Public Health, 33 pp.

Annotation: This toolkit provides dentists with resources to support judicious use of antibiotics in outpatient settings as part of the Illinois Precious Drugs & Scary Bugs Campaign. The toolkit is organized around four core elements set forth by the Centers for Disease Control and Prevention: commitment, action for policy and practice, tracking and reporting, and education and expertise.

Contact: Illinois Department of Public Health, Division of Oral Health, 535 West Jefferson Street, Third Floor, Springfield, IL 62761, Telephone: (217) 785-4899 Secondary Telephone: (800) 547-0466 Fax: (217) 524-4201 Web Site: http://www.dph.illinois.gov/topics-services/prevention-wellness/oral-health

Keywords: Antibiotics, Illinois, Oral health, Prescription drugs, Public awareness campaigns, Dentists, State programs

Oregon Health Authority, Oral Health Unit. 2017. Opioid prescribing guidelines for dentists. Portland, OR: Oregon Health Authority, Oral Health Unit, 1 p.

Annotation: This document for dentists provides guidelines on prescribing opioids. Appropriate dosages, types of medication to prescribe, prescribing refills, using guidelines for pain management, and ensuring that patients know how to secure medication and dispose of leftover medication are discussed. Alternatives to prescribing opioids are presented. Information is included on how to obtain the document in large print, Braille, non- English languages, or other formats.

Contact: Oregon Health Authority, Oral Health Program, 800 N.E. Oregon Street, Suite 850, Portland, OR 97232, Telephone: (971) 673-0348 Secondary Telephone: (971) 673-0372 Fax: (971) 673-0240 E-mail: oral.health@state.or.us Web Site: https://public.health.oregon.gov/PreventionWellness/oralhealth/Pages/index.aspx

Keywords: Guidelines, Medications, Opiates, Pain, Non English language materials, Prescription drugs

Children's Safety Network. 2016. Medication abuse prevention: 2016 resource guide. Waltham, MA: Children's Safety Network, 19 pp.

Annotation: This guide describes organizations, policy and legislation, prevention programs, publications, and webinars focused on prescription drug overdose prevention among youth and young adults. Contents include descriptions of reports, guides, toolkits, campaigns, website, iinitiatives, and research studies. Each item includes a short description and a link to the resource itself. Information about child safety and neonatal abstinence syndrome are included. [Funded by the Maternal and Child Health Bureau]

Contact: Children's Safety Network, Education Development Center, 43 Foundry Avenue, Waltham, MA 02453-8313, Telephone: (617) 618-2918 Fax: (617) 969-9186 E-mail: csninfo@edc.org Web Site: http://www.childrenssafetynetwork.org Available from the website.

Keywords: Adolescents, Children, Drug effects, Infants, Legislation, Multimedia, Neonatal abstinence syndrome, Policy development, Prescription drugs, Resource materials, Resources for professionals, Safety, Substance abuse prevention, Substance abuse prevention programs, Young adults

Rudd RA, Seth P, Felicita D, Scholl L. 2016. Increases in drug and opioid-involved overdose deaths: United States, 2010–2015. Morbidity and Mortality Weekly Report 65(50–51):1445–1452,

Annotation: This report examines overall drug overdose death rates during 2010-2015 and opioid overdose death rates during 2014–2015 by subcategories (natural/semisynthetic opioids, methadone, heroin, and synthetic opioids other than methadone). Rates are stratified by demographics, region, and by 28 states with high quality reporting on death certificates of specific drugs involved in overdose deaths. Implications for public health practice are included.

Contact: Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 E-mail: cdcinfo@cdc.gov Web Site: http://www.cdc.gov Available from the website.

Keywords: Chronic pain, Collaboration, Drug addiction, Heroin, Illicit drugs, Methadone, Mortality rates, Opiates, Prescription drugs, Substance abuse prevention, Substance abuse treatment services

U.S. Government Accountability Office. 2015. Prenatal drug use and newborn health: Federal efforts need better planning and coordination. Washington, DC: U.S. Government Accountability Office,

Annotation: This report provides information on how federal agencies have addressed opioid use by pregnant women and neonatal abstinence syndrome (NAS). Topics include federally funded research, federal programs, and other federal agency efforts related to prenatal opioid use or NAS; gaps identified by federal agency officials and experts in efforts to address prenatal opioid use or NAS; and how federal efforts to address prenatal opioid use or NAS are planned and coordinated.

Contact: U.S. Government Accountability Office, 441 G Street, N.W., Washington, DC 20548, Telephone: (202) 512-3000 Secondary Telephone: E-mail: contact@gao.gov Web Site: http://www.gao.gov Available from the website.

Keywords: Analgesic drugs, Federal agencies, Infant health, Newborn infants, Prenatal influences, Prevention, Program coordination, Program development, Program planning, Referrals, Research, Screening, Substance use

Fobbs E, Grady K, Chiang RJ, Zavacky F. 2015. State school health policy matrix 2.0. [Atlanta, GA]: National Association of Chronic Disease Directors; [Washington, DC]: National Association of State Boards of Education; [Reston, VA]: Society of Health and Physical Educators, 31 pp.

Annotation: This guide outlines state-level school health policies related to competitive foods and beverages, physical education and physical activity, and administration of medication in the school environment. Contents include a direct link to the policy and information about which political entity or agency adopted the policy or issued guidance.

Contact: National Association of Chronic Disease Directors, 2200 Century Parkway, Suite 250, Atlanta, GA 30345, Telephone: (770) 458-7400 Web Site: http://www.chronicdisease.org Available from the website.

Keywords: Drugs, Health policy, Physical activity, Physical education, Policy development, School food services, Schools, Service delivery systems

Centers for Disease Control and Prevention. 2014-. Treating for two: Safer medication use in pregnancy. Atlanta, GA: Centers for Disease Control and Prevention, 1 v.

Annotation: This website provides resources from an initiative to prevent birth defects and improve the health of mothers by identifying alternatives for treatment of common conditions during pregnancy and during the childbearing years. Contents include information and resources for parents and clinicians on medication use before and during pregnancy, and while breastfeeding. Topics include planning for pregnancy, the effects of medications during pregnancy, lists of safe medications during pregnancy, discussing current medications, accidental exposure, and a peer-reviewed database of drugs to which women who are breastfeeding may be exposed.

Contact: Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 E-mail: cdcinfo@cdc.gov Web Site: http://www.cdc.gov Available from the website.

Keywords: Adverse effects, Breastfeeding, Drug therapy, Drugs, Federal initiatives, Pregnancy, Pregnant women, Self medication

U.S. Preventive Services Task Force. 2014. Drug use, illicit: Primary care interventions for children and adolescents. Rockville, MD: U.S. Preventive Services Task Force, multiple items.

Safe Kids Worldwide. 2014. Keeping families safe around medicine. Washington, DC: Safe Kids Worldwide, 22 pp.

Lorenzo SB. 2014. Medications: Professional resource brief (2nd ed., upd.). Washington, DC: National Center for Education in Maternal and Child Health, 1 p.

Lorenzo SB. 2014. Tobacco, alcohol, and substance use during preconception and pregnancy: Professional resource brief (upd. ed.). Washington, DC: National Center for Education in Maternal and Child Health, 1 p.

U.S. Government Accountability Office. 2014. Foster children: Additional federal guidance could help states better plan for oversight of psychotropic medications administered by managed care plans. Washington, DC: U.S. Government Accountability Office, 48 pp.

Annotation: This report updates the December 2011 report published by the U.S. Government Accountability Office on foster children in selected states that were prescribed psychotropic medications at rates higher than nonfoster children in Medicaid in 2008. The current report examines instances of foster children being prescribed psychotropic medications in the following five states: Florida, Massachusetts, Michigan, Oregon, and Texas. The report assesses the extent that documentation supported the use of psychotropic medications, describes states' policies related to psychotropic medication, and assesses the U.S. Department of Health and Human Services' actions since GAO's 2011 report.

Contact: U.S. Government Accountability Office, 441 G Street, N.W., Washington, DC 20548, Telephone: (202) 512-3000 Secondary Telephone: E-mail: contact@gao.gov Web Site: http://www.gao.gov Available from the website. Document Number: GAO-14-362.

Keywords: Drugs, Federal initiatives, Florida, Foster children, Massachusetts, Medicaid managed care, Mental health services, Michigan, Oregon, Policy analysis, State programs, Texas, Utilization review

    Next Page »

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.